FUCHS HENRY J - Insider Non-Derivative Transactions at BIOMARIN PHARMACEUTICAL INC (BMRN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 13, 2024, FUCHS HENRY J's relationship to BIOMARIN PHARMACEUTICAL INC (BMRN) is Officer (President, Worldwide R&D), and currently has 185,074 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BMRN insiders.

Data Source: SEC.
FUCHS HENRY J - Insider Non-Derivative Transactions of BMRN Common Stock
FUCHS HENRY J - Insider Non-Derivative Transactions at BMRN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 14, 2024 F -- (Common Stock) 12098 84.9 185074
May 1, 2024 Acquisition -- (Common Stock) 300 68.65 197172
Mar 16, 2024 F -- (Common Stock) 33485 83.87 196872
Mar 16, 2024 Acquisition -- (Common Stock) 18240 0 230357
Mar 6, 2024 Sell -- (Common Stock) 35341 85.18 212117
Feb 28, 2024 Acquisition -- (Common Stock) 30640 0 224894
Feb 28, 2024 Acquisition -- (Common Stock) 13326 0 238220
Feb 28, 2024 Acquisition -- (Common Stock) 9238 0 247458
Dec 2, 2023 Acquisition -- (Common Stock) 17750 0 194254
Aug 11, 2023 Sell -- (Common Stock) 12000 90.43 176187
Apr 29, 2023 Acquisition -- (Common Stock) 317 66.88 176504
Mar 17, 2023 F -- (Common Stock) 36000 93.41 188187
Mar 16, 2023 F -- (Common Stock) 4799 87.74 224187
Mar 16, 2023 Acquisition -- (Common Stock) 16840 0 228986
Mar 1, 2023 Acquisition -- (Common Stock) 36440 0 180534
Mar 1, 2023 Acquisition -- (Common Stock) 18220 0 198754
Mar 1, 2023 Acquisition -- (Common Stock) 13392 0 212146
Apr 30, 2022 Acquisition -- (Common Stock) 341 62.41 144094